Skybiotech Healthcare Ltd

Skybiotech Healthcare Annual General Meeting

Skybiotech Healthcare Ltd has issued the notice for its 43rd Annual General Meeting. The meeting is scheduled to be held on September 30, 2026.

Skybiotech Healthcare Annual Report

Skybiotech Healthcare Ltd has filed its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.

Skybiotech Healthcare Q1 FY27 Results: Net Loss of ₹0.6 Cr

Skybiotech Healthcare Ltd reported revenue from operations of ₹0.5 Cr (-79.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.

Key figure

Net loss ₹0.6 Cr

Skybiotech Healthcare Board Meeting Date

Skybiotech Healthcare Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve un-audited financial results for the quarter ended June 30, 2026.

Skybiotech Healthcare Other Announcement

Skybiotech Healthcare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, as required by SEBI regulations.

Skybiotech Healthcare Other Announcement

Skybiotech Healthcare Ltd has filed its quarterly shareholding pattern statement as per regulatory requirements. This document details the company's equity distribution across various shareholder categories.

Skybiotech Healthcare Q4 FY26 Results: Net Loss of ₹0.3 Cr, Loss Narrows

Skybiotech Healthcare Ltd reported revenue from operations of ₹1.8 Cr (+80.0% YoY) and a net loss of ₹0.3 Cr for Q4 FY26.

Key figure

Net loss ₹0.3 Cr

Skybiotech Healthcare Financial Results

Skybiotech Healthcare Limited approved its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. The board meeting concluded with an unmodified audit opinion.

Skybiotech Healthcare Board Meeting Date

Skybiotech Healthcare scheduled a board meeting for May 30, 2026, to approve audited annual financial results. The meeting will review the period ending March 31, 2026.

Skybiotech Healthcare Debt & Borrowing

Skybiotech Healthcare Ltd disclosed its status under the SEBI Large Corporate framework for FY 2026. The company reported zero outstanding borrowings as of March 31, 2026, confirming it does not meet the criteria for mandatory debt market sourcing.

Skybiotech Healthcare Q3 FY26 Results: Net Loss of ₹0.5 Cr, Loss Widens

Skybiotech Healthcare Ltd reported a net loss of ₹0.5 Cr for Q3 FY26.

Key figure

Net loss ₹0.5 Cr